Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Thyroid Autoantibodies in Women With and Without Thyroid Disorders in an Iodine-Replete Area Pubmed



Aminorroaya A1 ; Momenzadeh M1 ; Hovsepian S1 ; Haghighi S1 ; Amini M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Endocrine and Metabolism Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Eastern Mediterranean Health Journal Published:2008


Abstract

To compare the prevalence of positive autoantibodies in patients with thyroid disorders and healthy subjects in an iodine-replete area of the Islamic Republic of Iran, we studied 930 women in a clinic-based study: 698 patients (286 hypothyroid, 140 hyperthyroid, 272 with simple goitre) and 232 healthy women. Serum thyroxine (T4), triiodothyronine (T3), thyroid stimulating hormone, and antithyroid antibodies were measured. Positive autoantibodies were detected in 75.5% of patients with hypothyroidism, 73.6% of those with hyperthyroidism, 48.9% of those with simple goitre and 35.8% of the control group (P < 0.001). Autoimmunity may have a role in the genesis of common thyroid disorders.
Other Related Docs
12. Isfahan Thyroid Cohort Study (Itcs), Archives of Iranian Medicine (2021)
14. Association Between Serum Ferritin and Goitre in Iranian School Children, Journal of Health, Population and Nutrition (2010)
19. Congenital Hypothyroidism; Is There Any Familial Component?, Journal of Isfahan Medical School (2009)
26. The Role of Ultrasonography in Primary Congenital Hypothyroidism, Journal of Research in Medical Sciences (2011)
27. Zinc Status in Goitrous School Children of Semirom, Iran, Journal of Research in Medical Sciences (2009)
38. Prevalence of Permanent Congenital Hypothyroidism in Isfahan-Iran, International Journal of Preventive Medicine (2013)
42. Thyroid Cancer in Isfahan Province, Iran; Prevalence and Demographic Characteristics, Jundishapur Journal of Chronic Disease Care (2019)